Stem Point Capital LP Edgewise Therapeutics, Inc. Transaction History
Stem Point Capital LP
- $334 Billion
- Q3 2024
A detailed history of Stem Point Capital LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 19,900 shares of EWTX stock, worth $480,585. This represents 0.16% of its overall portfolio holdings.
Number of Shares
19,900
Previous 271,057
92.66%
Holding current value
$480,585
Previous $4.88 Billion
89.12%
% of portfolio
0.16%
Previous 1.43%
Shares
2 transactions
Others Institutions Holding EWTX
# of Institutions
191Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$363 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$215 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$145 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$141 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$134 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.53B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...